Exhibit 99.1
(2) Following the pro-rata distributions reported herein, the shares of Common Stock are held as follows: 1,116,596 shares of common stock held by Sanderling Venture Partners V, L.P., 273,434 shares of common stock held by Sanderling V Biomedical, L.P., 155,143 shares of common stock held by Sanderling V Limited Partnership, 138,046 shares of common stock held by Sanderling V Beteiligungs GmbH & Co. KG, 281,053 shares of common stock held by Sanderling V Biomedical Co-Investment Fund, L.P., 463,582 shares of common stock held by Sanderling Venture Partners V Co-Investment Fund, L.P., 891,189 shares of common stock held by Sanderling V Strategic Exit Fund, L.P. (collectively, the Sanderling V Shares), 797,346 shares of common stock held by Sanderling Venture Partners VI Co-Investment Fund, L.P., 15,431 shares of common stock held by Sanderling VI Beteiligungs GmbH & Co. KG, 18,384 shares of common stock held by Sanderling VI Limited Partnership (collectively, the Sanderling VI Shares) and 3,446 shares of common stock held by Middleton-McNeil Retirement Trust. Timothy J. Wollaeger, one of the Issuer’s directors, Fred A. Middleton, Robert G. McNeil and Timothy C. Mills share voting and investment power with respect to the Sanderling V Shares. Robert G. McNeil, Fred A. Middleton, Timothy C. Mills and Timothy J. Wollaeger share voting and investment power with respect to the Sanderling VI Shares. Fred A. Middleton and Robert G. McNeil share voting and investment power with respect to the shares held by the Middleton-McNeil Retirement Trust. Each of these individuals disclaims beneficial ownership of such securities, except to the extent of his or her pecuniary interest therein.
Exhibit 99.2
Signature of Reporting Persons:
This statement on Form 4 is filed is filed by Sanderling Venture Partners V, L.P., Sanderling V Biomedical, L.P., Sanderling V Limited Partnership, Sanderling V Beteiligungs GmbH & Co. KG, Sanderling V Ventures Management, Sanderling V Biomedical Co-Investment Fund, L.P., Sanderling Venture Partners V Co-Investment Fund, L.P., Sanderling V Strategic Exit Fund, L.P., Sanderling Venture Partners VI Co-Investment Fund, L.P., and Sanderling VI Beteiligungs GmbH & Co. KG. The principal business address of each of the reporting persons is c/o Sanderling Venture Partners V, L.P., 400 South El Camino Real, Suite 1200, San Mateo, CA 94402. The reporting entities disclaim beneficial ownership of the securities listed herein except to the extent of their pecuniary interest therein.
Sanderling Venture Partners V, L.P. By: Middleton, McNeil & Mills Associates V, LLC
By: /s/ Timothy J. Wollaeger Timothy J. Wollaeger Managing Director
|
Sanderling V Biomedical, L.P. By: Middleton, McNeil & Mills Associates V, LLC
By: /s/ Timothy J. Wollaeger Timothy J. Wollaeger Managing Director
|
Sanderling V Limited Partnership By: Middleton, McNeil & Mills Associates V, LLC
By: /s/ Timothy J. Wollaeger Timothy J. Wollaeger Managing Director
|
Sanderling V Beteiligungs GmbH & Co. KG By: Middleton, McNeil & Mills Associates V, LLC
By: /s/ Timothy J. Wollaeger Timothy J. Wollaeger Managing Director
|
Sanderling V Ventures Management
By: /s/ Timothy J. Wollaeger Timothy J. Wollaeger Owner
|
Sanderling V Biomedical Co-Investment Fund, L.P. By: Middleton, McNeil & Mills Associates V, LLC
By: /s/ Timothy J. Wollaeger Timothy J. Wollaeger Managing Director
|
Sanderling Venture Partners V Co-Investment Fund, L.P. By: Middleton, McNeil & Mills Associates V, LLC
By: /s/ Timothy J. Wollaeger Timothy J. Wollaeger Managing Director
|
Sanderling V Strategic Exit Fund, L.P. By: Middleton, McNeil, & Mills Associates V, LLC
By: /s/ Timothy J. Wollaeger Timothy J. Wollaeger Managing Director
|
Sanderling Venture Partners VI Co-Investment Fund, L.P. By: Middleton, McNeil, Mills & Associates VI, LLC
By: /s/ Timothy J. Wollaeger Timothy J. Wollaeger Managing Director
|
Sanderling VI Beteiligungs GmbH & Co. KG By: Middleton, McNeil, Mills & Associates VI, LLC
By: /s/ Timothy J. Wollaeger Timothy J. Wollaeger Managing Director
|